BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12565747)

  • 1. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
    Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland.
    da Silveira RB; Pigozzo RB; Chaim OM; Appel MH; Dreyfuss JL; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
    Biochimie; 2006 Sep; 88(9):1241-53. PubMed ID: 16581177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom.
    Kalapothakis E; Araujo SC; de Castro CS; Mendes TM; Gomez MV; Mangili OC; Gubert IC; Chávez-Olórtegui C
    Toxicon; 2002 Dec; 40(12):1691-9. PubMed ID: 12457881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical and immunological characteristics of Peruvian Loxosceles laeta spider venom: neutralization of its toxic effects by anti-loxoscelic antivenoms.
    Guimarães G; Dias-Lopes C; Duarte CG; Felicori L; Machado de Avila RA; Figueiredo LF; de Moura J; Faleiro BT; Barro J; Flores K; Silva W; Tintaya B; Yarleque A; Bonilla C; Kalapothakis E; Salas CE; Chávez-Olortegui C
    Toxicon; 2013 Aug; 70():90-7. PubMed ID: 23648420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
    Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
    Guilherme P; Fernandes I; Barbaro KC
    Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
    Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
    Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
    Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses.
    Figueiredo LF; Dias-Lopes C; Alvarenga LM; Mendes TM; Machado-de-Ávila RA; McCormack J; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2014 Aug; 86():59-67. PubMed ID: 24878371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and neutralization of biological activities in the venoms of Loxosceles spiders.
    Barbaro KC; Ferreira ML; Cardoso DF; Eickstedt VR; Mota I
    Braz J Med Biol Res; 1996 Nov; 29(11):1491-7. PubMed ID: 9196551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
    Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
    Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders.
    Souza NA; Dias-Lopes C; Matoso ÍHG; de Oliveira CFB; Chávez-Olortegui CD; Minozzo JC; Felicori LF
    Vaccine; 2018 Nov; 36(48):7324-7330. PubMed ID: 30352745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.
    Alvarenga LM; Martins MS; Moura JF; Kalapothakis E; Oliveira JC; Mangili OC; Granier C; Chávez-Olórtegui C
    Toxicon; 2003 Dec; 42(7):725-31. PubMed ID: 14757202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom.
    Mendes TM; Oliveira D; Figueiredo LF; Machado-de-Avila RA; Duarte CG; Dias-Lopes C; Guimarães G; Felicori L; Minozzo JC; Chávez-Olortegui C
    Vaccine; 2013 Jun; 31(25):2749-55. PubMed ID: 23664158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and immunological cross-reactivity of LALP3, a novel astacin-like metalloprotease from brown spider (Loxosceles intermedia) venom.
    Morgon AM; Belisario-Ferrari MR; Trevisan-Silva D; Meissner GO; Vuitika L; Marin B; Tashima AK; Gremski LH; Gremski W; Senff-Ribeiro A; Veiga SS; Chaim OM
    Biochimie; 2016; 128-129():8-19. PubMed ID: 27343628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
    de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
    Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, cloning and functional characterization of a novel dermonecrotic toxin (phospholipase D) from brown spider (Loxosceles intermedia) venom.
    Appel MH; da Silveira RB; Chaim OM; Paludo KS; Silva DT; Chaves DM; da Silva PH; Mangili OC; Senff-Ribeiro A; Gremski W; Nader HB; Veiga SS
    Biochim Biophys Acta; 2008 Feb; 1780(2):167-78. PubMed ID: 18082635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism.
    Karim-Silva S; Moura Jd; Noiray M; Minozzo JC; Aubrey N; Alvarenga LM; Billiald P
    Immunol Lett; 2016 Aug; 176():90-6. PubMed ID: 27288291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermonecrotic and lethal components of Loxosceles gaucho spider venom.
    Barbaro KC; Cardoso JL; Eickstedt VR; Mota I
    Toxicon; 1992 Mar; 30(3):331-8. PubMed ID: 1326796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brown spider dermonecrotic toxin directly induces nephrotoxicity.
    Chaim OM; Sade YB; da Silveira RB; Toma L; Kalapothakis E; Chávez-Olórtegui C; Mangili OC; Gremski W; von Dietrich CP; Nader HB; Sanches Veiga S
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):64-77. PubMed ID: 16005484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.